Acrivon Therapeutics Inc

NASDAQ:ACRV 3:59:52 PM EDT

22.55

+0.42 (+1.90%)

5:10:43 PM EDT: $21.80 -0.75 (-3.33%)

Acrivon Therapeutics Inc Stock, NASDAQ:ACRV

480 Arsenal Way, Suite 100, Watertown, Massachusetts 02472

United States of America

Phone: +1.617.207.8979

Number of Employees:

http://acrivon.com

Description

Acrivon Therapeutics, Inc. develops drugs for clinical treatment. Its unique precision medicine platform, called Acrivon Predictive Precision Proteomics (AP3), for development of drug pipeline. Its AP3 is used to generate proprietary OncoSignature companion diagnostics to identify the patients who will benefit from the medicines. The company was founded by Peter Blume-Jensen and Kristina Masson on March 03, 2018 and is headquartered in Watertown, MA.